Targeting of Drugs 3: The Challenge of Peptides and Proteins

The Use of Derivatives of MSH for Targeting to Melanomas In Vivo ; D.R. Bard, et al. The Development of Ricin AChain Immunotoxins for Clinical Trials in Patients with Hodgkin's Disease; A. Angert, P. Thorpe. Ribosome-Inactivating Proteins from Sponaria Officinalis; M.R. Soria, et al. Targeting with IgG and Immunoliposomes to Circulating Cells; D.J.A. Crommelin, et al. Liposome and Immunoliposome Mediated Delivery of Proteins and Peptides; L. Huang, F. Zhou. Sterically Stabilized Liposomes as Drug Carriers; A. Gabizon, et al. Liposomes as Immunological Adjuvants; G. Gregoriadis. Targeting Proteins to Antigen-Presenting Cells and Induction of Cytokines as a Basis for Adjuvant Activity; A.C. Allison, N.E. Byars. Oral Administration of Peptides; M. Saffran. Oral Administration of Insulin; M. Saffran. Neuropeptide-Mediated Growth of Normal and Cancer Cells; E. Rozengurt, T. Sethi. Bacterial Vectors to Target and/or Purify Polypeptides; M. Hofnung, et al. Index.